Meg Knowling

Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial

Joseph Ragaz, Ivo A. Olivotto, John J. Spinelli et al. · JNCI Journal of the National Cancer Institute · 2005 · 1K citations · Full text

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

Meg Knowling, Martin E. Blackstein, Richard Tozer et al. · Investigational New Drugs · 2006 · 83 citations

National Cancer Institute, Malignant Disease, Medicine +7

A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200

Quincy Chu, Torsten O. Nielsen, Thierry Alcindor et al. · Annals of Oncology · 2015 · 45 citations · Full text

Tumor Biology, Medicine, Immunology +7

Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma

V. Bramwell, E. A. Eisenhauer, Martin E. Blackstein et al. · Annals of Oncology · 1995 · 45 citations · Full text

Pancoast Syndrome, Surgical Oncology, Medicine +7

Patterns of relapse in breast cancer: changes over time

Rinat Yerushalmi, Ryan Woods, Hagen F. Kennecke et al. · Breast Cancer Research and Treatment · 2009 · 34 citations

Breast Oncology, Medicine, Cancer Recurrence +4